selected scholarly activity
-
academic article
- 5-year incidence of suicide-risk in youth: A gradient tree boosting and SHAP study. Journal of Affective Disorders. 295:1049-1056. 2021
- Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study report. Journal of Affective Disorders. 295:1095-1101. 2021
- Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report. Translational Psychiatry. 11:469. 2021
- Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report. Communications Biology. 4:903. 2021
- Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study report. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 111:110194-110194. 2021
- Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response. Translational Psychiatry. 11:439. 2021
- Exploring brain connectivity changes in major depressive disorder using functional‐structural data fusion: A CAN‐BIND‐1 study. Human Brain Mapping. 42:4940-4957. 2021
- Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report. Psychoneuroendocrinology. 132:105348-105348. 2021
- Brain age in mood and psychotic disorders: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica. 2021
- Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1. Canadian Journal of Psychiatry. 66:798-806. 2021
- Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. Pharmacopsychiatry. 54:225-231. 2021
- The role of emotion dysregulation in cognitive behavioural group therapy for perinatal anxiety: Results from a randomized controlled trial and routine clinical care. Journal of Affective Disorders. 292:517-525. 2021
- Sleep, biological rhythms and anxiety in the perinatal period: a systematic review protocol. BMJ Open. 11:e046767-e046767. 2021
- Cognitive Behavior Therapy for Women With Generalized Anxiety Disorder in the Perinatal Period: Impact on Problematic Behaviors. Behavior Therapy. 52:907-916. 2021
- Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force. Bipolar Disorders. 2021
- Cognitive complaints in individuals recently diagnosed with bipolar disorder: A cross-sectional study. Psychiatry Research. 300:113894-113894. 2021
- Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Translational Psychiatry. 11:127. 2021
- White matter microstructure in youth at risk for serious mental illness: A comparative analysis. Psychiatry Research - Neuroimaging. 312:111289-111289. 2021
- Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN‐BIND 1 report. Personality and Mental Health. 2021
- Depression in midlife women attending a menopause clinic is associated with a history of childhood maltreatment. Climacteric. 1-5. 2021
- Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. CNS Drugs. 35:439-450. 2021
- Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. CNS Drugs. 35:291-304. 2021
- Novel mechanism of action for the mood stabilizer lithium. Bipolar Disorders. 23:76-83. 2021
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur. Canadian Journal of Psychiatry. 66:113-125. 2021
- The Revised Mood Rhythm Instrument: A Large Multicultural Psychometric Study. Journal of Clinical Medicine Journal of Clinical Medicine Journal of Clinical Medicine. 10:388-388. 2021
- Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review. Frontiers in Psychiatry. 12:719241. 2021
- Multisite Comparison of MRI Defacing Software Across Multiple Cohorts. Frontiers in Psychiatry. 12:617997. 2021
- Predicting Brain Age at Slice Level: Convolutional Neural Networks and Consequences for Interpretability. Frontiers in Psychiatry. 12:598518. 2021
- Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1. PLoS ONE. 16:e0253023-e0253023. 2021
- Neural correlates of verbal recognition memory in obese adults with and without major depressive disorder. Brain and Behavior. 10:e01848. 2020
- Quality assurance assessment of a specialized perinatal mental health clinic. BMC Pregnancy and Childbirth. 20:485. 2020
- Validation of the English version of the Mood Rhythm Instrument. BMC psychology. 8:35. 2020
- Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 50:2536-2547. 2020
- Measuring circadian function in bipolar disorders: Empirical and conceptual review of physiological, actigraphic, and self‐report approaches. Bipolar Disorders. 22:693-710. 2020
- The Early Burden of Disability in Individuals With Mood and Other Common Mental Disorders in Ontario, Canada. JAMA network open. 3:e2020213-e2020213. 2020
- Objective and subjective vasomotor symptom outcomes in the CBT-Meno randomized controlled trial. Climacteric. 23:482-488. 2020
- Understanding the complex interplay between violence, depression and suicidal ideation in women: Time for a comprehensive sex- and gender-based approach. Revista Brasileira de Psiquiatria. 42:467-468. 2020
- Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study. Psychiatry and Clinical Neurosciences. 74:418-423. 2020
- Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Archives of Women's Mental Health. 23:493-505. 2020
- Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Neuropsychopharmacology. 45:1390-1397. 2020
- THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.. Innovations in Clinical Neuroscience. 17:30-40. 2020
- Toward prevention of bipolar disorder in at-risk children: Potential strategies ahead of the data. Journal of Affective Disorders. 272:508-520. 2020
- Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder. Journal of Clinical Psychiatry. 81. 2020
- Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants. Human Brain Mapping. 41:1400-1415. 2020
- Cognitive behavioral therapy for perinatal anxiety: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry. 54:423-432. 2020
- Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach. Australian and New Zealand Journal of Psychiatry. 54:393-401. 2020
- Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report. International Journal of Neuropsychopharmacology. 23:88-95. 2020
- Emotional reactivity and explicit emotional memory biases in major depressive disorder during euthymia. Psychiatry Research. 285:112847-112847. 2020
- Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study. Journal of Affective Disorders. 264:414-424. 2020
- Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers. Journal of Affective Disorders. 263:353-366. 2020
- Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression. JAMA network open. 3:e1918377-e1918377. 2020
- An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report. NeuroImage: Clinical. 25:102178-102178. 2020
- Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Stroke Patients. Journal of Stroke and Cerebrovascular Diseases. 29:104502-104502. 2020
- Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology. 45:283-291. 2020
- Structural and Functional Brain Correlates of Neuroprogression in Bipolar Disorder. Current Topics in Behavioral Neurosciences. 48:197-213. 2020
- The Link between Estradiol and Neuroplasticity in Transgender Women after Gender-Affirming Surgery: A Bimodal Hypothesis. Neuroendocrinology. 110:489-500. 2020
- Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational Psychiatry. 9:254. 2019
- Validation and psychometric properties of the Spanish Mood Rhythm Instrument. Biological Rhythm Research. 1-13. 2019
- Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study. Journal of Affective Disorders. 257:765-773. 2019
- White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 4:913-924. 2019
- Cognitive behavior therapy for menopausal symptoms (CBT-Meno). Menopause. 26:972-980. 2019
- Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial.. Menopause. 26:972-980. 2019
- Effort-based decision-making is affected by overweight/obesity in major depressive disorder. Journal of Affective Disorders. 256:221-227. 2019
- Explicit emotional memory biases in mood disorders: A systematic review. Psychiatry Research. 278:162-172. 2019
- Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. NeuroImage. 197:589-597. 2019
- The use of cannabinoids for sleep: A critical review on clinical trials.. Experimental and Clinical Psychopharmacology. 27:383-401. 2019
- Association of functioning and quality of life with objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder. Australian and New Zealand Journal of Psychiatry. 53:683-696. 2019
- Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 49:1629-1638. 2019
- The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 44:223-236. 2019
- Inter-rater reliability of DartfishTM movement analysis software for measuring maximum flexion and extension at the hip and knee in older adults with osteoporosis and osteopenia. Physiotherapy Theory and Practice. 35:577-585. 2019
- Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. Journal of Clinical Psychiatry. 80. 2019
- Biological and psychosocial predictors of anxiety worsening in the postpartum period: A longitudinal study. Journal of Affective Disorders. 250:218-225. 2019
- From anatomy to function: the role of the somatosensory cortex in emotional regulation. Revista Brasileira de Psiquiatria. 41:261-269. 2019
- Impact of a structured, group-based running programme on clinical, cognitive and social function in youth and adults with complex mood disorders: a 12-week pilot study. BMJ Open Sport and Exercise Medicine. 5:e000521-e000521. 2019
- Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial. Journal of Psychopharmacology. 33:502-510. 2019
- Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review. Alcoholism: Clinical and Experimental Research. 43:550-563. 2019
- Cerebral cortical thickness after treatment with desvenlafaxine succinate in major depressive disorder. NeuroReport. 30:378-382. 2019
- Age-related deficits in intracortical myelination in young adults with bipolar disorder type I. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 44:79-88. 2019
- Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder. Journal of Clinical Psychiatry. 80. 2019
- Altered hippocampal function with preserved cognitive performance in treatment-naive major depressive disorder. NeuroReport. 30:46-52. 2019
- Cortical thickness in major depressive disorder: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 88:287-302. 2019
- Effects of Estradiol Therapy on Resting-State Functional Connectivity of Transgender Women After Gender-Affirming Related Gonadectomy. Frontiers in Neuroscience. 13:817. 2019
- A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women. European Archives of Psychiatry and Clinical Neuroscience. 268:771-781. 2018
- Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. Australian and New Zealand Journal of Psychiatry. 52:1173-1182. 2018
- Rhythmicity of Mood Symptoms in Individuals at Risk for Psychiatric Disorders. Scientific Reports. 8:11402. 2018
- Structural and functional changes in the somatosensory cortex in euthymic females with bipolar disorder. Australian and New Zealand Journal of Psychiatry. 52:1075-1083. 2018
- Non-pharmacological interventions for improving postpartum maternal sleep: A systematic review and meta-analysis. Sleep Medicine Reviews. 41:87-100. 2018
- Risk factors of new onset anxiety and anxiety exacerbation in the perinatal period: A systematic review and meta-analysis. Journal of Affective Disorders. 238:626-635. 2018
- The Menopause Visual Analogue Scale: a new tool for measuring the severity and response to treatment of symptoms throughout the menopausal transition. Climacteric. 21:502-508. 2018
- Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 43:298-316. 2018
- The Role of Circadian Rhythms in Postpartum Sleep and Mood. Sleep Medicine Clinics. 13:359-374. 2018
- Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review.. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 43:298-316. 2018
- Association of intracortical myelin and cognitive function in bipolar I disorder. Acta Psychiatrica Scandinavica. 138:62-72. 2018
- Effects of a 12-week running programme in youth and adults with complex mood disorders. BMJ Open Sport and Exercise Medicine. 4:e000314-e000314. 2018
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. 20:97-170. 2018
- The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study. Journal of Affective Disorders. 227:542-549. 2018
- Performance of the biological rhythms interview for assessment in neuropsychiatry: An item response theory and actigraphy analysis. Journal of Affective Disorders. 225:54-63. 2018
- Prospective Assessment of Daily Patterns of Mood-Related Symptoms. Frontiers in Psychiatry. 9:370. 2018
- Volumetric MRI Analysis of a Case of Severe Ventriculomegaly. Frontiers in Human Neuroscience. 12:495. 2018
- Salivary cortisol during memory encoding in pregnancy predicts postpartum depressive symptoms: a longitudinal study. Trends in Psychiatry and Psychotherapy. 39:280-284. 2017
- Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression. Scientific Reports. 7:7473. 2017
- Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Archives of Women's Mental Health. 20:713-719. 2017
- Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study. Acta Psychiatrica Scandinavica. 136:473-482. 2017
- Altered intracortical myelin staining in the dorsolateral prefrontal cortex in severe mental illness. European Archives of Psychiatry and Clinical Neuroscience. 267:369-376. 2017
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications. 8:15497. 2017
- A statistical method to calculate blood contamination in the measurement of salivary hormones in healthy women. Clinical Biochemistry. 50:436-439. 2017
- Influence of endogenous estradiol, progesterone, allopregnanolone, and dehydroepiandrosterone sulfate on brain resting state functional connectivity across the menstrual cycle. FERTILITY AND STERILITY. 107:1246-1255.e4. 2017
- Age-related mapping of intracortical myelin from late adolescence to middle adulthood using T1-weighted MRI. Human Brain Mapping. 38:3691-3703. 2017
- Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life. Revista Brasileira de Psiquiatria. 39:140-146. 2017
- Resting state functional connectivity in women with bipolar disorder during clinical remission. Bipolar Disorders. 19:97-106. 2017
- Subtle persistent working memory and selective attention deficits in women with premenstrual syndrome. Psychiatry Research. 249:354-362. 2017
- Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression. Scientific Reports. 7:41382. 2017
- Convergent lines of evidence support the role of uric acid levels as a potential biomarker in bipolar disorder. Expert Review of Molecular Diagnostics. 17:107-108. 2017
- Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder. Frontiers in Psychiatry. 8:301. 2017
- The impact of obesity on neuropsychological functioning in adults with and without major depressive disorder. PLoS ONE. 12:e0176898-e0176898. 2017
- Biological rhythms are independently associated with quality of life in bipolar disorder. International Journal of Bipolar Disorders. 4:9. 2016
- Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry. 16:105. 2016
- RNA-sequencing profiles hippocampal gene expression in a validated model of cancer-induced depression. Genes, Brain and Behavior. 15:711-721. 2016
- Update on bipolar disorder biomarker candidates. Expert Review of Molecular Diagnostics. 16:1209-1220. 2016
- Biological rhythms, metabolic syndrome and current depressive episode in a community sample. Psychoneuroendocrinology. 72:34-39. 2016
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. Canadian Journal of Psychiatry. 61:588-603. 2016
- Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study. Revista Brasileira de Psiquiatria. 38:190-196. 2016
- The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder.. Innovations in Clinical Neuroscience. 13:20-31. 2016
- Sleep, daily activity rhythms and postpartum mood: A longitudinal study across the perinatal period. Chronobiology International Annual Review of Chronopharmacology. 33:791-801. 2016
- Do changes in subjective sleep and biological rhythms predict worsening in postpartum depressive symptoms? A prospective study across the perinatal period. Archives of Women's Mental Health. 19:591-598. 2016
- Mild Depressive Symptoms During the Third Trimester of Pregnancy Are Associated with Disruptions in Daily Rhythms but Not Subjective Sleep Quality. Journal of Women's Health. 25:594-598. 2016
- The Mood Rhythm Instrument: development and preliminary report. Revista Brasileira de Psiquiatria. 38:148-153. 2016
- Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 41:E22-E23. 2016
- Effect of obesity on cognition in adults with and without a mood disorder: study design and methods. BMJ Open. 6:e009347-e009347. 2016
- The association between biological rhythms, depression, and functioning in bipolar disorder: a large multi-center study. Acta Psychiatrica Scandinavica. 133:102-108. 2016
- Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression. Behavioural Brain Research. 294:25-35. 2015
- Emotional memory in pregnant women at risk for postpartum depression. Psychiatry Research. 229:777-783. 2015
- Cognitive-behavioral group treatment for perinatal anxiety: a pilot study. Archives of Women's Mental Health. 18:631-638. 2015
- Assessing intracortical myelin in the living human brain using myelinated cortical thickness. Frontiers in Neuroscience. 9:396. 2015
- Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?. Neural Plasticity Journal of Neural Transplantation and Plasticity. 2015:1-12. 2015
- Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord. PLoS ONE. 10:e0142598-e0142598. 2015
- Translational Research in Bipolar Disorders. Neural Plasticity Journal of Neural Transplantation and Plasticity. 2015:1-3. 2015
- Comparative Efficacy of the Generalized Anxiety Disorder 7-Item Scale and the Edinburgh Postnatal Depression Scale as Screening Tools for Generalized Anxiety Disorder in Pregnancy and the Postpartum Period. Canadian Journal of Psychiatry. 59:434-440. 2014
- Alterations in circadian rhythms are associated with increased lipid peroxidation in females with bipolar disorder. International Journal of Neuropsychopharmacology. 17:715-722. 2014
- Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial. Acta Psychiatrica Scandinavica. 129:393-400. 2014
- Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder. Bipolar Disorders. 16:48-57. 2014
- Changes in cortical thickness across the lifespan in major depressive disorder. Psychiatry Research - Neuroimaging. 214:204-211. 2013
- New-onset psychosis following androgen deprivation therapy for prostate cancer.. Canadian Journal of Urology. 20:6868-6870. 2013
- Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated Bipolar Disorder Guidelines. Bipolar Disorders. 15:338-339. 2013
- Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Australian and New Zealand Journal of Psychiatry. 47:321-332. 2013
- A primary care-based treatment programme improves postpartum depression at 12 months. Evidence-Based Mental Health. 16:6-6. 2013
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders. 15:1-44. 2013
- Comorbid bipolar disorder and premenstrual dysphoric disorder: real patients, unanswered questions. Archives of Women's Mental Health. 16:79-81. 2013
- Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder. Archives of Women's Mental Health. 16:83-85. 2013
- Soft Bipolar Spectrum and Staging in Bipolar Disorder. Current Psychiatry Reviews. 9:33-40. 2013
- The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disorders. 15:58-60. 2013
- The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder. European Psychiatry. 28:21-29. 2013
- Sensitivity and Specificity of the Mood Disorder Questionnaire as a Screening Tool for Bipolar Disorder During Pregnancy and the Postpartum Period. Journal of Clinical Psychiatry. 73:1456-1461. 2012
- Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder. Journal of Psychiatric Research. 46:1511-1514. 2012
- Increased cerebral oxidative damage and decreased antioxidant defenses in ovariectomized and sham-operated rats supplemented with vitamin A. Cell Biology and Toxicology. 28:317-330. 2012
- Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder. Oxidative Medicine and Cellular Longevity. 2012:1-13. 2012
- Depression in Women. Journal of Clinical Psychiatry. 72:e1563-e1569. 2011
- Sleep and Circadian Rhythm Disturbances in Bipolar Disorder. Journal of Clinical Psychiatry. 72:724-724. 2011
- Non-Hormonal Treatment Strategies for Vasomotor Symptoms. Drugs. 71:287-304. 2011
- Is there a role for estrogen in treating depression during menopause?. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 35:E6-E7. 2010
- A Pilot, 8-Week, Placebo Lead-In Trial of Quetiapine Extended Release for Depression in Midlife Women. Journal of Clinical Psychopharmacology. 30:612-615. 2010
- The rapid effects of estrogen: a mini-review. Behavioural Pharmacology. 21:465-472. 2010
- Gender differences in α-[11C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: A positron emission tomography study. Psychiatry Research - Neuroimaging. 183:157-166. 2010
- Shift in the brain network of emotional regulation in midlife women. Menopause. 17:840-845. 2010
- Approach to Premenstrual Dysphoria for the Mental Health Practitioner. Psychiatric Clinics of North America. 33:257-272. 2010
- Challenges and Opportunities to Manage Depression During the Menopausal Transition and Beyond. Psychiatric Clinics of North America. 33:295-308. 2010
- Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disorders. 11:663-671. 2009
- Clinical implications of a staging model for bipolar disorders. Expert Review of Neurotherapeutics. 9:957-966. 2009
- Neuronal Correlates of Brain-derived Neurotrophic Factor Val66Met Polymorphism and Morphometric Abnormalities in Bipolar Disorder. Neuropsychopharmacology. 34:1904-1913. 2009
- Marcadores de estrés oxidativo en el trastorno bipolar: un metaanálisis. Psiquiatria Biologica. 16:60-69. 2009
- Early intervention in bipolar disorders: Clinical, biochemical and neuroimaging imperatives. Journal of Affective Disorders. 114:1-13. 2009
- Brain-derived neurotrophic factor in bipolar disorder: beyondtraitandstate: comment on ‘Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders’. Bipolar Disorders. 11:221-222. 2009
- Electrophysiological correlates of sleep disturbance induced by acute and chronic administration of d-amphetamine. Brain Research Brain Research Protocols Molecular Brain Research. 1249:162-172. 2009
- Managing Depression and Anxiety during the Menopausal Transition and Beyond: The Window of Vulnerability. Key Issues in Mental Health. 175:102-114. 2009
- Increased oxidative stress as a mechanism for the decreased levels of BDNF in acute manic episodes (vol 30, pg 243, 2008). Revista Brasileira de Psiquiatria. 30:432-432. 2008
- Oxidative stress markers in bipolar disorder: A meta-analysis. Journal of Affective Disorders. 111:135-144. 2008
- Corrected values of brain metabolites for the article: ‘Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: anin vivo1H MRS study’. Bipolar Disorders. 10:849-849. 2008
- Effects of mood stabilizers on DNA damage in an animal model of mania.. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 33:516-524. 2008
- Illness duration and total brain gray matter in bipolar disorder: Evidence for neurodegeneration?. European Neuropsychopharmacology. 18:717-722. 2008
- Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Journal of the British Menopause Society Menopause international. 14:123-128. 2008
- Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Revista Brasileira de Psiquiatria. 30:243-245. 2008
- Insight, quality of life and cognitive functioning in euthymic patients with bipolar disorder. Journal of Affective Disorders. 110:75-83. 2008
- Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience. 258:300-304. 2008
- Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Review of Neurotherapeutics. 8:1101-1113. 2008
- Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. Journal of Psychiatric Research. 42:416-421. 2008
- Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Human Psychopharmacology. 23:87-94. 2008
- Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neuroscience and Biobehavioral Reviews. 32:675-692. 2008
- Mismatch between self-reported quality of life and functional assessment in acute mania: A matter of unawareness of illness?. Journal of Affective Disorders. 103:247-252. 2007
- Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder. NeuroReport. 18:1567-1570. 2007
- DNA damage in bipolar disorder. Psychiatry Research. 153:27-32. 2007
- Manic symptoms and quality of life in bipolar disorder. Psychiatry Research. 153:33-38. 2007
- The role of hippocampus in the pathophysiology of bipolar disorder. Behavioural Pharmacology. 18:419-430. 2007
- DNA damage in rats after treatment with methylphenidate. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 31:1282-1288. 2007
- Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo1H MRS study. Bipolar Disorders. 9:119-127. 2007
- Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behavioural Pharmacology. 18:205-212. 2007
- Anxiety Comorbidity and Quality of Life in Bipolar Disorder Patients. Canadian Journal of Psychiatry. 52:175-181. 2007
- Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neuroscience Letters. 415:87-89. 2007
- Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Molecular Psychiatry. 12:230-231. 2007
- Fluvoxamina no transtorno depressivo maior: um estudo multicêntrico aberto. Jornal Brasileiro de Psiquiatria. 56:17-22. 2007
- Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 31:283-285. 2007
- Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neuroscience Letters. 407:146-150. 2006
- Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 31:326-332. 2006
- Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 30:1231-1234. 2006
- Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sciences. 79:281-286. 2006
- Glial fibrillary acidic protein expression after electroconvulsive shocks in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 30:663-667. 2006
- Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disorders. 8:275-280. 2006
- Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Research Brain Research Protocols Molecular Brain Research. 1097:224-229. 2006
- Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behavioural Pharmacology. 17:311-318. 2006
- Changes in Antioxidant Defense Enzymes after d-amphetamine Exposure: Implications as an Animal Model of Mania. Neurochemical Research. 31:699-703. 2006
- Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters. 398:215-219. 2006
- Pharmacological treatment of bipolar disorder: Evidence from randomized clinical trials. Revista de Psiquiatria Clinica. 32:34-38. 2005
- A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania. Human Psychopharmacology. 20:133-139. 2005
- Neurobiological basis of bipolar disorder. Revista de Psiquiatria Clinica. 32:28-33. 2005
- A integração da psicofarmacoterapia e psicoterapia de orientação analítica: uma revisão crítica. Revista Brasileira de Psiquiatria. 26:118-123. 2004
- Mycoplasma pneumoniae pneumonia: clinical and radiological features. Jornal de Pediatria. 76:315-22. 2000
- Population-based study on the prevalence of gastroesophageal reflux disease in Porto Alegre, Rio Grande do Sul. GED - Gastrenterologia Endoscopia Digestiva. 19:73-78. 2000
- The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. 73:237-250. 1999
- Investigation of Blood-Brain Barrier Disruption in an Animal Model of Mania Induced by d-Amphetamine
- The PPD-ACT App: Feasibility of a mobile application for recruiting women with postpartum depression and psychosis to a psychiatric genetics study (Preprint)
-
chapter
- Oncodynamic Effect of Cancer on Depression. 105-127. 2016
- Bipolar Disorder in Women. 463-476. 2010
-
conference paper
- Risk factors for new-onset bipolar disorder in a community cohort: A five-year follow up study. Psychiatry Research. 2021
- M31 IMPACT OF CYP2C19 AND CYP2D6 GENE VARIANTS ON PLASMA LEVELS AND TREATMENT RESPONSE IN PATIENTS RECEIVING ESCITALOPRAM AND ARIPIPRAZOLE FOR MAJOR DEPRESSION: RESULTS FROM THE CAN-BIND-1 COHORT. European Neuropsychopharmacology. S183-S183. 2019
- CANNABIDIOL AS A NOVEL CANDIDATE ALCOHOL USE DISORDER PHARMACOTHERAPY: A SYSTEMATIC REVIEW. Alcoholism: Clinical and Experimental Research. 249A-249A. 2019
- F107. Cortical Thickness Features Differentiate 16-Week Antidepressant Response Profiles in Major Depressive Disorder. Biological Psychiatry. S254-S254. 2019
- F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder. Biological Psychiatry. S257-S257. 2019
- F119. Age Trajectory of Deep White Matter Intensity in Bipolar Disorder Type-I Using MRI. Biological Psychiatry. S259-S259. 2019
- S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort. Biological Psychiatry. S344-S345. 2019
- T97. Predicting Functioning and Quality of Life Using Objective and Subjective Measures of Sleep and Biological Rhythms in Major Depressive and Bipolar Disorder. Biological Psychiatry. S166-S166. 2019
- Diagnosis and treatment of women with co-morbid bipolar and premenstrual dysphoric disorder. Bipolar Disorders. 53-54. 2019
- Explicit emotional memory in major depressive disorder during euthymia. Bipolar Disorders. 150-151. 2019
- Intracortical Myelin as a novel neurobiological correlate of psychosocial functioning in bipolar I disorder. Bipolar Disorders. 76-77. 2019
- Lifetime cocaine use predicts conversion from major depressive disorder to bipolar disorder: A prospective 3-year follow-up study. Bipolar Disorders. 95-96. 2019
- Management of bipolar disorder in pregnancy and the postpartum period. Bipolar Disorders. 49-50. 2019
- Predicting functioning and quality of life using objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder. Bipolar Disorders. 58-58. 2019
- The influence of endogenous DHEAS on mood in women with bipolar disorder with and without comorbid PMDD. Bipolar Disorders. 61-61. 2019
- Trauma, cocaine use and female sex predict transition from major depression to bipolar disorder. Bipolar Disorders. 56-56. 2019
- S120. Canadian Biomarker Integration Network in Depression (CAN-BIND): Baseline and Follow up Neurocognitive Mediators of Functioning in Major Depressive Disorder (MDD). Biological Psychiatry. S393-S394. 2018
- S34. New Onset Anxiety and Anxiety Exacerbation in the Perinatal Period: A Systematic Review and Meta-Analysis. Biological Psychiatry. S360-S360. 2018
- Brain structure and function in women with co-morbid bipolar and premenstrual dysphoric disorder. Bipolar Disorders. 55-55. 2018
- Correlations between endogenous hormones and resting-state functional connectivity in bipolar disorder with and without comorbid premenstrual dysphoric disorder. Bipolar Disorders. 75-76. 2018
- Emotional memory in bipolar disorder and major depressive disorder: a preliminary report. Bipolar Disorders. 102-103. 2018
- Objective sleep and daytime activity in bipolar and major depressive disorder. Bipolar Disorders. 20-21. 2018
- The impact of female reproductive life events on women with bipolar disorder: a clinical perspective. Bipolar Disorders. 26-26. 2018
- VItex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Bipolar Disorders. 140-140. 2018
- Effects of Tryptophan Depletion on Mood, Vasomotor Symptoms and Sleep in Midlife Women on Estrogen Therapy: Double Blind Placebo-Controlled Crossover Trial. Menopause. 1460-1461. 2017
- The Effects of Acute Tryptophan Depletion on Emotional Stroop in Midlife Women Receiving Estrogen-based Treatment: An fMRI study. Menopause. 1453-1453. 2017
- 468. Impact of Biological Rhythms on Perinatal Anxiety: A Prospective Investigation in Pregnant Women with Mood Disorders. Biological Psychiatry. S191-S191. 2017
- Changes in biological rhythms and mood from pregnancy to early postpartum in women with mood disorders: preliminary results. Bipolar Disorders. 139-139. 2017
- Circadian rhythmopathy - a shared timer for dopamine - dependent features in bipolar disorder? biological rhythms across the perinatal period in women with mood disorders: a longitudinal, replication and expansion study. Bipolar Disorders. 38-39. 2017
- Earlier illness onset and increased hormonal sensitivity in women with co-morbid bipolar and premenstrual dysphoric disorder: clinical and treatment implications. Bipolar Disorders. 60-60. 2017
- Evidence of deficits in intracortical maturation in bipolar I disorder: a 3T MRI study. Bipolar Disorders. 33-33. 2017
- Global deficits in intracortical myelin maturation in young adults with bipolar I disorder. Bipolar Disorders. 80-80. 2017
- Increased illness burden in women with co-morbid bipolar and premenstrual dysphoric disorder: data from the large step-BD study. Bipolar Disorders. 90-90. 2017
- Neurobiological correlates of co-morbid bipolar and premenstrual dysphoric disorder. Bipolar Disorders. 83-83. 2017
- Impact of Tryptophan Depletion on Sleep Efficiency during the Menopausal Transition while on Estrogen Therapy: Preliminary Results. Menopause. 1394-1395. 2016
- Resting-state fMRI after Acute Tryptophan Depletion in Perimenopause Women on Estrogen Therapy: Preliminary Results. Menopause. 1400-1400. 2016
- Validation of the Menopause Visual Analogue Scale in Determining Mood and Physical Symptoms of Perimenopausal Women on Estrogen Treatment. Menopause. 1395-1395. 2016
- Diagnostic accuracy of measures evaluating premenstrual dysphoric disorder in women with comorbid bipolar and major depressive disorder. Bipolar Disorders. 162-163. 2016
- Intracortical myelin content in the DLPFC predicts verbal memory, and self-reported cognitive and psychosocial functioning in bipolar disorder. Bipolar Disorders. 74-74. 2016
- Objective parameters of sleep and circadian rhythms: an actigraph and melatonin study in bipolar and major depressive disorder. Bipolar Disorders. 45-45. 2016
- Prospective investigation of subjective measures of biological rhythms across the perinatal period in women with bipolar disorder. Bipolar Disorders. 163-163. 2016
- Resting state prefrontal cortical connectivity in women with bipolar disorder during euthymia: a seed-based analysis. Bipolar Disorders. 74-74. 2016
- Neural Correlates of Resting State Functional Connectivity in Women with Bipolar Disorder in Remission: An ICA and Seed Based Analysis. Biological Psychiatry. 120S-120S. 2016
- Objective Validation of the Biological Rhythms Interview for Assessment in Neuropsychiatry (BRIAN): Preliminary Analyses. Biological Psychiatry. 55S-55S. 2016
- Resting State Functional Connectivity and Emotional Stroop Activation Across the Menstrual Cycle in Women with no History of PMDD. Biological Psychiatry. 242S-242S. 2016
- Examining Differences in Cortical Thickness in Perimenopausal Middle Aged Females with Major Depressive Disorder and Healthy Controls. Menopause. 1389-1390. 2015
- Hippocampal volumetric analysis in unmedicated midlife women with major depressive disorder. Menopause. 1390-1391. 2015
- Co-morbid bipolar and premenstrual dysphoric disorder: from hormones to brain circuits and behavior. Bipolar Disorders. 48-48. 2015
- Differences in resting state connectivity between follicular and luteal menstrual cycle phases in euthymic women with bipolar disorder. Bipolar Disorders. 126-126. 2015
- Longitudinal assessment of circadian rhythms in women at risk for postpartum depression. Bipolar Disorders. 27-27. 2015
- MAC-PMSS: preliminary analyses of a new DSM-5-based tool to monitor concurrent mood and premenstrual symptoms. Bipolar Disorders. 120-121. 2015
- Women with history of mood disorders show greater circadian rhythm disruption across the perinatal period: preliminary analyses of a longitudinal study. Bipolar Disorders. 108-108. 2015
- Changes in Grey and White Matter Volume in Midlife in Men and Women with Major Depressive Disorder. Biological Psychiatry. 2015
- Circadian Phase-Delay During Pregnancy Predicts the Severity of Postpartum Depressive Symptoms in Women at Risk for Postpartum Depression. Biological Psychiatry. 390S-390S. 2015
- Discrepancy Between Subjective and Objective Parameters of Sleep and Biological Rhythms in Pregnant Women with Mood Disorders. Biological Psychiatry. 2015
- Alterations in Biological Rhythms but not Sleep Quality Predict Severity of Depressive Symptoms in Late Pregnancy. Biological Psychiatry. 126S-126S. 2014
- Cognitive Profile of Obese Adults with and without a Mood Disorder. Biological Psychiatry. 55S-55S. 2014
- Emotional Memory in Pregnant Women with and Without Major Depression. Biological Psychiatry. 197S-197S. 2014
- Lack of Concordance between Multiplex and Enzyme-Linked Immunosorbent Assay in the Measurement of Cytokines in Human Serum: Implications for Studies of Low-Grade Systemic Inflammation. Biological Psychiatry. 384S-384S. 2014
- The Impact of Pre-Pregnancy Body Mass Index on Autonomic Function and Circadian Rhythms during Pregnancy: Preliminary Results. Biological Psychiatry. 268S-268S. 2014
- Circadian rhythm disruption in women with bipolar and premenstrual dysphoric disorder during remission: preliminary results. Bipolar Disorders. 77-77. 2014
- Does pregnancy affect circadian rhythms in women with mood disorders during remission?. Bipolar Disorders. 77-78. 2014
- Serum myelin oligodendrocyte glycoprotein levels are stable in depressed females with bipolar disorder. Bipolar Disorders. 72-72. 2014
- A double challenge: pregnancy and post-partum in bipolar disorder. Bipolar Disorders. 156-156. 2013
- Circadian rhythm is a strong predictor of quality of life in females with bipolar disorder. Bipolar Disorders. 107-107. 2013
- Longitudinal assessment of changes in circadian rhythms and risk for postpartum depression: a preliminary analysis. Bipolar Disorders. 107-107. 2013
- Markers of lipid peroxidation are not altered in depressed and euthymic females with bipolar disorder. Bipolar Disorders. 56-56. 2013
- Depression and Cardiovascular Disease in Women: Does This Comorbidity Have an Immunological Basis? A Theoretical Synthesis. Biological Psychiatry. 325S-325S. 2013
- Depressive Symptoms in Late Pregnancy are Associated with a Systemic Pro-Inflammatory Cytokine Profile. Biological Psychiatry. 325S-325S. 2013
- Heightened Systemic Inflammation: A State or a Trait Marker for Major Depression During Late Pregnancy?. Biological Psychiatry. 203S-203S. 2013
- Heightened Systemic Inflammation: A State or a Trait Marker for Major Depression During Late Pregnancy?. Biological Psychiatry. 313S-313S. 2013
- Impact of Circadian Rhythm, Sleep Quality and Depression Severity on Quality of Life in Females with Bipolar Disorder. Biological Psychiatry. 59S-59S. 2013
- Impact of Estrogen Levels and Severity of Depressive Symptoms on Brain Cortical Thickness in Unmedicated Peri/Postmenopausal Women with Depression. Biological Psychiatry. 186S-186S. 2013
- Blood Contamination in the Measurement of Salivary Hormones in Healthy Women. Biological Psychiatry. 285S-285S. 2012
- Changes in Cortical Thickness Across Adulthood in Major Depressive Disorder. Biological Psychiatry. 199S-200S. 2012
- Mechanistic Pathways for the Antidepressant Effects of Estradiol in Perimenopausal Women with MDD: An Acute Tryptophan Depletion, fMRI Proof-of-Concept. Biological Psychiatry. 200S-200S. 2012
- Peripheral Biomarkers in New Onset of Major Depressive Disorder in Midlife Women: The Harvard Study of Moods and Cycles. Biological Psychiatry. 278S-278S. 2012
- Severity of Depressive Symptoms in Late Pregnancy Depends on the Interaction Between Circadian Rhythm and Sleep Disturbances. Biological Psychiatry. 278S-278S. 2012
- A functional MRI investigation of the neural correlates of declarative and recognition memory in obese patients with bipolar disorder. Bipolar Disorders. 117-117. 2012
- Default mode network in children at risk for bipolar disorder: preliminary resting-state fMRI findings. Bipolar Disorders. 83-83. 2012
- Sensitivity and specificity of the Mood Disorders Questionnaire as a screening for bipolar disorder during pregnancy and postpartum. Bipolar Disorders. 41-41. 2012
- Antidepressant Effects on Brain Activation During the Emotional Conflict Task in Perimenopausal Women: a Functional MRI Study. Menopause. 1371-1371. 2011
- Cortical Thickness Analysis in Depressed, Medication-free, Perimenopausal and Postmenopausal Women. Menopause. 1348-1349. 2011
- Effects of Quetiapine Extended-Release on Sleep and Quality of Life in Midlife Women With Major Depressive Disorder. Menopause. 1371-1371. 2011
- A longitudinal assessment of serum Brain Derived Neurotrophic Factor levels in bipolar patients. Bipolar Disorders. 51-51. 2011
- An Exploration of the Impact of Weight Loss on Declarative Memory and Executive Functioning in Bipolar and Major Depressive Disorders. Biological Psychiatry. 173S-173S. 2011
- Emotional Conflict in Offspring of Bipolar Parents - Preliminary fMRI Findings. Biological Psychiatry. 165S-165S. 2011
- Frontal Executive Attention Network in Medication-Free Women With Depression during Menopausal Transition: Normalization of Prefrontal Cortical Hyperactivation after Antidepressant Treatment. Biological Psychiatry. 181S-181S. 2011
- Are Neurocognitive Complaints Persistent During the Follicular Phase in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder?. Biological Psychiatry. 66S-66S. 2010
- Gene Expression of Estrogen Receptor alpha and Serotonin Transporter in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Biological Psychiatry. 55S-55S. 2010
- Imaging and Cognitive Tasks in Clinical Interventions for Female-Specific Mood Disorders. Biological Psychiatry. 174S-174S. 2010
- Neuronal Correlates of Regulation of Emotional Conflict in Women During Menopausal Transition. Biological Psychiatry. 137S-137S. 2010
- Making sense of findings of brain imaging in bipolar disorder. Bipolar Disorders. 60-60. 2010
- Shift in the brain network of emotional regulation in midlife women: Is the menopausal transition the turning point?. International Journal of Neuropsychopharmacology. 44-44. 2010
- Brain-derived neurotrophic factor levels and cognitive dysfunction in euthymic bipolar type I patients. Bipolar Disorders. 88-88. 2009
- MIDLIFE WOMEN WITH MAJOR DEPRESSIVE DISORDER: EFFECTS OF QUETIAPINE EXTENDED-RELEASE ON MOOD, SLEEP AND MENOPAUSE-RELATED SYMPTOMS. European Psychiatry. 2009
- Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: A combined α-[11C]MT and [18F]MPPF positron emission tomography study. NeuroImage. 850-857. 2008
- Three-Dimensional Mapping of Hippocampal Anatomy in Unmedicated and Lithium-Treated Patients with Bipolar Disorder. Neuropsychopharmacology. 1229-1238. 2008
- Brain-derived neurotrophic factor val66met polymorphism and morphometric abnormality in bipolar disorder patients. Biological Psychiatry. 141S-141S. 2007
- Cox-2 inhibitor (Celecoxib) as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study. Biological Psychiatry. 171S-171S. 2007
- Effects of BDNF val66met polymorphism on brain neurochemistry in bipolar disorder patients: A 1H MRS study. Biological Psychiatry. 59S-59S. 2007
- A cox-2 inhibitor (celecoxib) as a possible adjunctive agent to expedite treatment response in bipolar depression. Neuropsychopharmacology. S163-S164. 2006
- Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology. S148-S148. 2006
- Lower creatine plus phosphocreatine in the left dorsolateral prefrontal cortex in unmedicated bipolar disorder subjects: A magnetic resonance spectroscopy study. Biological Psychiatry. 58S-58S. 2006
- Lower creatine plus phosphocreatine in the left dorsolateral prefrontal cortex in unmedicated bipolar disorder subjects: A magnetic resonance spectroscopy study. Biological Psychiatry. 141S-141S. 2006